Estrogen and estrogen receptors in thyroid carcinomas

Area of Science:

• Endocrinology
• Oncology
• Pathology

Background:

• Estrogen receptors (ER) and estradiol (E2) play roles in various physiological processes.
• Aberrant estrogen signaling is implicated in the development and progression of certain cancers.
• The role of estrogen in thyroid tissue, particularly in thyroid neoplasms, requires further investigation.

Purpose of the Study:

• To investigate the presence and levels of estrogen receptors (ER) and estradiol (E2) in different thyroid tissue types.
• To explore potential associations between ER/E2 expression and specific thyroid pathologies, including papillary carcinoma.
• To examine possible correlations between E2-positivity and clinical behavior, such as relapse, in papillary thyroid carcinomas.

Main Methods:

• Enzyme-immunoassay was used to quantify ER levels in normal thyroid, Graves' thyroid, and papillary carcinoma tissues.
• Immunohistochemical analysis was performed to detect E2 presence in normal thyroid, Graves' disease, follicular adenoma, and papillary carcinoma tissues.
• Statistical analysis was conducted to compare ER/E2 levels across tissue types and correlate E2-positivity with patient demographics and disease relapse.

Main Results:

• Papillary carcinoma tissues exhibited significantly higher mean ER levels compared to normal thyroid and Graves' thyroid tissues.
• E2-positive tissues were found in a substantial proportion of papillary carcinomas (76%), Graves' thyroids (40%), and follicular adenomas (50%).
• E2-positivity was observed in both male and female patients with papillary carcinoma, with slightly higher rates in males.
• No significant difference in E2-positivity was found between papillary carcinomas with and without relapse.

Conclusions:

• Thyroid carcinomas, particularly papillary carcinomas, may exhibit estrogen dependency.
• The study suggests a potential role for estrogen in thyroid tumorigenesis.
• Further research is needed to establish definitive links between E2-positivity and the biological behavior of thyroid tumors.